Financial Incentives to Improve Medication Adherence
1 other identifier
interventional
25
1 country
1
Brief Summary
Medication adherence is a challenge in all of medicine and is associated with multiple negative outcomes. Strategies to better measure and enhance adherence to medication are urgent and necessary to minimize unwanted health outcomes, hospitalizations, poorer quality of life and excessive costs for individuals, insurers and caregivers. Recently, behavioral economics-based approaches have emerged as a promising tool to address this unmet need, but its effectiveness in oral antipsychotic treatment remains to be assessed. For this project, investigators will use an app that offers financial incentives to increase compliance for patients with chronic diseases. Investigators intend to enroll 25 patients in a pilot project to assess feasibility of offering financial incentives to improve medication adherence in severe mental illness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable schizophrenia
Started Nov 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2019
CompletedFirst Submitted
Initial submission to the registry
December 2, 2019
CompletedFirst Posted
Study publicly available on registry
December 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 2, 2022
CompletedSeptember 21, 2023
September 1, 2023
7 months
December 2, 2019
September 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in medication adherence rate
Adherence rate will be measured as pills missed/pills prescribed
Between baseline and study completion (10 weeks)
Study Arms (1)
Active
EXPERIMENTALThis study has only one arm. All patients enrolled will take part in the experimental arm.
Interventions
Patients who are willing to participate will be offered financial incentives for medication adherence through an app (Wellth) over 10 weeks.
Eligibility Criteria
You may qualify if:
- Psychiatric patients with suspected or confirmed poor oral medication adherence.
- Age 18-80 years old
- English speaking, since the app being used is only available in English
- Owning a Smartphone, since the app requires a Smartphone to work
- Willing and able to participate.
You may not qualify if:
- Acute anger to self or others as per investigator assessment
- Unwilling or unable to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwell Healthlead
Study Sites (1)
The Zucker Hillside Hospital
Glen Oaks, New York, 11004, United States
Related Publications (1)
Guinart D, Sobolev M, Patil B, Walsh M, Kane JM. A Digital Intervention Using Daily Financial Incentives to Increase Medication Adherence in Severe Mental Illness: Single-Arm Longitudinal Pilot Study. JMIR Ment Health. 2022 Oct 12;9(10):e37184. doi: 10.2196/37184.
PMID: 36222818DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 2, 2019
First Posted
December 10, 2019
Study Start
November 1, 2019
Primary Completion
May 30, 2020
Study Completion
March 2, 2022
Last Updated
September 21, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share